AGP
VERA icon

Artia Global Partners’s Vera Therapeutics VERA Stock Holding History

Artia Global Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,298
Closed -$1.05M – 55
2024
Q1 		$1.05M Buy
+24,298
New +$866K 0.21% 40

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Artia Global Partners's VERA Position: Q2 2024 in Review

Artia Global Partners sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 24,298 shares — an estimated $1.05M sold.

Artia Global Partners first reported a position in VERA in Q1 2024 and held it in 1 quarter. The position peaked at $1.05M in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

  • Artia Global Partners reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Artia Global Partners sold 24,298 Vera Therapeutics shares in Q2 2024, an estimated $1.05M.
  • Artia Global Partners first reported a position in Vera Therapeutics in Q1 2024 and held it in 1 quarter.
  • Artia Global Partners's Vera Therapeutics position peaked at $1.05M in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on Artia Global Partners's 13F filing for Q2 2024, filed 14 Aug 2024.